Search for: "Boehringer Ingelheim Pharmaceutical, Inc"
Results 41 - 60
of 124
Sort by Relevance
|
Sort by Date
20 Nov 2012, 8:32 am
This settlement was with pharmaceutical giant Boehrigner Ingelheim Pharmaceuticals Inc. [read post]
9 Nov 2012, 2:15 pm
" November 7, 2012: "Interim Results from RELY-ABLE®, the RE-LY® Extension Study, Provide Additional Clinical Evidence for the Safety of Pradaxa® (dabigatran etexilate mesylate)" (Drug company Press Release) @EXCERPT: Boehringer Ingelheim Pharmaceuticals, Inc. today announced interim results from the RELY-ABLE® trial, a long-term extension of the RE-LY® study. [read post]
2 Nov 2012, 11:58 am
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
29 Oct 2012, 11:40 am
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
28 Oct 2012, 6:37 pm
Boehringer Ingelheim Pharmaceuticals Inc., a Germany-based pharmaceutical company that markets and sells drugs in the United States, has recently agreed to settle claims that it illegally promoted four of its best-selling drugs for $95 million. [read post]
26 Oct 2012, 4:31 am
According to DOJ’s press release: Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD) drugs Atrovent and Combivent, and the hypertension drug Micardis, the Justice Department announced today. [read post]
20 Aug 2012, 2:01 pm
These Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc. [read post]
20 Aug 2012, 2:01 pm
These Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc. [read post]
20 Aug 2012, 11:15 am
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against… [read post]
6 Aug 2012, 2:29 pm
A man has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
3 Aug 2012, 4:45 am
A man from neighboring Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 9:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 12:42 pm
Two more plaintiffs have come forward seeking drug injury compensation from Boehringer Ingelheim Pharmaceuticals Inc. for the harm they have suffered from taking Pradaxa. [read post]
8 Jul 2012, 9:13 pm
• Defendants: Roxane Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. [read post]
15 Jun 2012, 2:51 pm
Pradaxa Approved by FDA in 2010 and Investigated by 2011 In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. [read post]
15 Jun 2012, 2:51 pm
Pradaxa Approved by FDA in 2010 and Investigated by 2011 In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. [read post]
2 May 2012, 11:11 am
According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible. [read post]
